Figure 3.
B-cell lymphoma phenotypes in IgH-c-myc transgenic mice. (A) A typical flow cytometry analysis for B-cell lymphoma phenotyping. One representative experiment for a B220+CD19+IgM+IgD+CD43−CD117−CD138− B-cell lymphoma is shown. (B) Percentage of mature (IgM+IgD+) and immature (IgM+/−IgD−) B-cell lymphomas (24 c-myc-KIEμ, 19 c-myc-KICμ, and 37 c-myc-KICα mice). (C) Percentages of CD138+ mature B-cell lymphomas in c-myc-KIEμ, c-myc-KICμ, and c-myc-KICα mice. The number (n) of mice for each group is indicated. (D) Percentages of CD19− mature B-cell lymphomas in c-myc-KIEμ, c-myc-KICμ, and c-myc-KICα mice. Same mice as in panel C.

B-cell lymphoma phenotypes in IgH-c-myc transgenic mice. (A) A typical flow cytometry analysis for B-cell lymphoma phenotyping. One representative experiment for a B220+CD19+IgM+IgD+CD43CD117CD138 B-cell lymphoma is shown. (B) Percentage of mature (IgM+IgD+) and immature (IgM+/−IgD) B-cell lymphomas (24 c-myc-KIEμ, 19 c-myc-KICμ, and 37 c-myc-KICα mice). (C) Percentages of CD138+ mature B-cell lymphomas in c-myc-KIEμ, c-myc-KICμ, and c-myc-KICα mice. The number (n) of mice for each group is indicated. (D) Percentages of CD19 mature B-cell lymphomas in c-myc-KIEμ, c-myc-KICμ, and c-myc-KICα mice. Same mice as in panel C.

Close Modal

or Create an Account

Close Modal
Close Modal